Toll-like receptor 3 (TLR3) belongs to a family of evolutionary conserved innate immune recognition molecules and recognizes double-stranded (ds)RNA, a molecular pattern associated with viral infections. Earlier studies suggested a differential expression pattern in men and mice, the molecular basis for this observation, however, was unknown. Here we demonstrate that species-specific differences in tissue expression and responses to lipopolysaccaride (LPS) coincide with the presence of different, evolutionary non-conserved promoter sequences in both species. Despite the overall unrelatedness of TLR3 promoter sequences, mRNA expression of both TLR3 orthologues was induced by interferons, particularly by IFN-β. The basal and IFN-β-induced activation of promoters from both species largely depended on similar interferon regulatory factor (IRF) elements which constitutively bound IRF-2 and recruited IRF-1 after stimulation. In murine macrophages, IFN-β-induced TLR3 up-regulation required IFNAR1, STAT1, and in part IRF-1, but not the Janus kinase (Jak) family member Tyk2. We also show that LPS specifically upregulates TLR3 expression in murine cells through the induction of autocrine/paracrine IFN-β. In humans, however, IFN-β induced upregulation of TLR3 was blocked by pretreatment with LPS, despite the efficient induction of IRF-1. Our findings reveal a mechanistic basis for the observed differences as well as similarities in TLR3 expression in men and mice. The IFN-β -TLR3 link further suggests a role of TLR3 in innate and adaptive immune responses to viral infections. It will be interesting and important to clarify whether the observed differences in the transcriptional regulation of TLR3 influence innate immune responses in a species-specific manner.
INTRODUCTION
Vertebrate Toll-like receptors (TLRs 1 ) recognize conserved microbial structures (pathogenassociated molecular patterns, PAMPs). Upon ligation they activate conserved intracellular signaling pathways, leading to the up-regulation of co-stimulatory molecules or the secretion of cytokines -responses that are necessary to combat infection in vertebrates (as reviewed in (1;2)).
Two recent studies have implicated Toll-like receptor 3 (TLR3) in the recognition of doublestranded RNA, a molecular pattern associated with viral infections (3;4) . Activation of the receptor with a chemical analog of double-stranded RNA, polyriboinosine-polyribocytidylic acid (poly(I:C)), was shown to induce the activation of NF-kB and the production of type I interferons (IFNs) in human and murine TLR3 expressing cell types (3;4). TLR3-deficient (TLR3-/-) mice exhibited reduced responses to poly(I:C), and reduced production of the inflammatory cytokines IL-6, IL-12 and TNF (3) . A contribution of TLR3 to antiviral immunity,
however, remains to be demonstrated.
Interestingly, different TLR3 expression patterns have been reported in mice and humans, a phenomenon also observed for at least three other TLR family members: TLR2, TLR4 and TLR9
(for a review see Ref (5)). Within the human hematopoietic compartment, TLR3 mRNA expression has been shown to be restricted to dendritic cells (6) , as was the cytokine response to poly(I:C) stimulation (7) . In mice, TLR3 is also strongly expressed in macrophages and its expression is markedly induced upon LPS stimulation -a feature that has not been observed in human cells (3) .
Since the differential expression pattern of TLR3 could have a significant impact on TLR3 function in humans and mice, we have further characterized TLR3 expression and analyzed gene regulatory mechanisms acting in both species. We found that the non-coding regions, including 5'-exons and proximal promoter regions of TLR3 genes are different in both species, as is the RNA-preparation, Real-time-PCR. Total RNA was isolated from different cell types by the guanidine thiocyanate/acid phenol method (15) . RNA (1 µg) was reverse transcribed using Superscript II MMLV-RT (Invitrogen). Real-time PCR was performed on a Lightcycler (Roche) controlled by agarose gel electrophoresis and melting curves were analysed to control for specificity of the PCR reactions. TLR data were normalized for expression of the housekeeping gene β-actin. The relative units were calculated from a standard curve plotting 3 different concentrations of log dilutions against the PCR cycle number (CP) at which the measured fluorescence intensity reaches a fixed value. The amplification efficiency E was calculated from the slope of the standard curve by the formula: E = 10 -1/slope . E TLR3 was in the range of 1,78 to 2,14, E TLR2 ranged from 1,76 to 1,84. For each sample data of 3 independent analyses were averaged. 7 products from both species were cloned into pCR2.1-TOPO (TOPO Cloning Kit, Invitrogen) and inserts from at least 10 individual plasmid-containing bacterial colonies derived from each cell type were re-amplified by PCR and directly sequenced (performed by GENEART, Regensburg, Germany).
Plasmid construction and purification. A 588 bp genomic fragment of the human TLR3-promoter was amplified from human genomic DNA using the Expand High Fidelity PCR system (Roche Biochemicals) and the primers hTLR3p_S (5'-GAT CAG ATC TCA GCT TTG CCA TGT TTG G -3') and hTLR3p_AS (5'-ACG TGA ATT CTG TTG GAT GAC TGC TAG CCT TTC C -3'). Primer sequences were derived from a BAC clone containing the TLR3 sequence deposited in the Genbank database (Genbank accession no AC104070). The obtained PCR fragment was subcloned into pGL3-B (Promega) and sequenced. Deletions of the hTLR3 (-588) construct were generated by PCR using primers hTLR3(-400)_S (5'-GTC AAG ATC TTC GCA TGA GTC TAG CAG -3') or hTLR3(-200)_S (5'-GAC TAG ATC TGG TTT GAA ACG CCT CTC TG -3') together with the vector-specific primer GL2 (Gibco). Two fragments of the proximal murine TLR3 promoter (including intron 1 and exon2) were similarly amplified from mouse genomic DNA using the primers mtlr3-F1_S (5'-TGC AAG ATC TGA GTG TAG CCA   TGA GCC AGG -3') and mtlr3-F2_AS (5'-CAT CAA GCT TCT ATC TTC TTT TGG TGC GCG -3'). Deletions of the resulting mtlr3(-1368) construct were generated using the internal Sac I (-966) or EcoR I (-429) restriction sites. Mutations of putative transcription factor binding sites were carried out by PCR-mediated mutagenesis using the following primers: human ISRE/IRF element: htlr3IRF-M_S (5'-TTT TCA AGC TTT ACA CGC ACT TTC GAG AGT G-3') and htlr3IRF-M_AS (5'-CAC TCT CGA AAG TGC GTG TAA AGC TTG AAA A-3'); human 8 TTT CAG GCT GA-3') and mtlr3IRFi-M_AS (5'-TCA GCC TGA AAG TGC GTC TTA AGT   TGA GAG AG-3'); murine intron 1 ISRE/IRF element: mtlr3IRFo-M_S (5'-GGT AAG TGA   ATG GCA CGC ACT TTG TTT AGA CA-3') and mtlr3IRFo-M_AS (5'-TGT CTA AAC AAA   GTG CGT GCC ATT CAC TTA CC-3' ). DNA sequence analysis was performed by GENEART (Regensburg, Germany). For transfections, plasmids were isolated and purified using the Endofree Plasmid Kit from Qiagen.
Transient and stable DNA transfections. THP-1 cells were transfected in duplicates using DEAE-dextran as described previously (16) . Undifferentiated THP-1 cells were cultivated for 48 h before harvesting. In stimulation experiments, THP-1 cells were treated with PMA the day after transfection and harvested after 72 h. Cell lysates were assayed for firefly and renilla luciferase activity using the Dual-Luciferase Reporter Assay System (Promega) on a Sirius luminometer (Berthold). Firefly luciferase activity of individual transfections was normalized against renilla luciferase activity. RAW264.7 cells were transfected using SuperFect reagent (Qiagen) according to the manufacturer's instructions as described (17) . Duplicate transfections were harvested after 24h and cell lysates assayed for firefly luciferase activity using the Luciferase Reporter Assay System (Promega). Firefly luciferase activity of individual transfections was normalized against protein concentration measured using a BCA assay (Sigma). For stimulation experiments, RAW264.7 cells were transfected in 10 cm tissue culture dishes as above using linearized reporter constructs (10 µg) as well as a plasmid (pCDNA3) carrying the neomycin resistance gene (5 µg). Cells were selected for stable integration of plasmid DNA by culturing cells in RPMI 1640 medium supplemented with 350 µg G418 for two to three weeks. Stably transfected cells were pooled, expanded and 7.5 x 10 5 cells/ml were seeded into six-well plates in duplicates the day before stimulation. Cells were harvested at the indicated timepoints and cell lysates were assayed as above.
Nuclear extracts and electrophoretic mobility shift assay. Nuclear extracts were prepared as described previously (16) . Double-stranded oligonucleotides corresponding to the STAT-or IRF-elements were labeled with α-[ Antisera used in supershift analyses were added after 15 min and samples were loaded onto polyacrylamide gels after incubating at room temperature for a total of 30 min. Buffers and running conditions used have been described (16) . Gels were fixed in 5% acetic acid, dried and autoradiographed.
RESULTS

TLR3 mRNA expression in murine and human mononuclear phagocytes.
Recently published data suggests a differential expression pattern of TLR3 in human and murine mononuclear cells (5) .
To directly compare the mRNA expression of TLR3 in human and murine cells, we designed PCR primers complementary to TLR3 sequences which are identical in both species. Real-time PCR using various mononuclear cell types from both species confirmed the previously observed predominant expression of human TLR3 in 'immature' myeloid dendritic cells (s. Figure 1 ).
Highest TLR3 expression levels in mice, however, were detectable in macrophages, which expressed the highest TLR3 mRNA levels of all tested cell types. These results indicated that cell type-specific regulation of TLR3 might be different between the two species. and IRF-2 were able to transactivate the human promoter in HT-29 cells (data not shown). We also performed gelshift assays to identify the nuclear proteins binding to the human STAT-motif.
Species-specific TLR3 regulation in response to LPS or
The STAT-motif specifically competed with the binding of STAT1 to a known STAT1 (GAS) binding site, indicating that STAT1 may be able to bind this site. However, we were unable to detect binding of STAT1 directly to the human STAT-motif in gelshift assays (data not shown).
For the murine gene, the role of several interferon signalling components in IFN-β induced TLR3 up-regulation including the IFN-α/β receptor (IFNAR1), STAT1, Tyk2 as well as IRF-1 was analyzed in either peritoneal macrophages or bone marrow-derived macrophages from knock-out mice lacking the respective genes. As shown in Figure 6 , up-regulation of TLR3 by IFN-β in peritoneal macrophages depends on IFNARI, but not on the Janus kinase (Jak) family member Tyk2. The induction of TLR3 in bone marrow-derived macrophages also depended on STAT1 as well as IRF-1, albeit to a lesser degree, indicating that other family members may compensate for IRF-1 deficiency. Using real-time PCR with species-overlapping primers, we could extend previously published observations, showing that among the human and murine cell types tested, the basal TLR3 expression levels are by far the highest in murine macrophages. In contrast, human monocytes and macrophages express relatively low basal levels of TLR3 and as observed before, human monocyte-derived dendritic cells express the highest TLR3 levels within the assayed human cells. The murine proximal TLR3 promoter was highly active in the murine macrophage cell line RAW264.7, whereas the human promoter was weakly active in these cells, indicating that the murine promoter regions contain elements required for a strong expression in macrophages. In line with these observations, the murine promoter (but not the human) contains a number of putative binding sites for the macrophage-and B-cell-specific transcription factor PU.1, which has been implicated in the regulation of a number of macrophage-specific genes (20;21). It is likely that the human promoter contains elements favoring TLR3 expression in human monocyte-derived dendritic cells. However, further investigations will be necessary to identify the exact elements regulating the basal cell type-specific expression in both species. In addition to the species variations in basal TLR3 expression, TLR3 has previously been shown to be induced by LPS in murine macrophages, but not in human cells. We have confirmed these observations for different human and murine cell types. Using blocking antibodies as well as knock-out mice, we were able to demonstrate that in murine macrophages, TLR3 mRNA is up- where IRF-2 acts as a transcriptional activator rather than a repressor.
Mechanism of LPS-induced
In conclusion, our observations suggest that the human and murine TLR3 genes are regulated through different promoter regions that likely mediate the observed species-specific variations in TLR3 expression. Further investigations are necessary to clarify whether the observed differences in basal cell type-specific and induced expression of TLR3 influence immune responses in both species. The marked up-regulation of TLR3 in response to type I interferons that was found to be mediated through the Jak-STAT-IRF signaling pathway, however, appears to be conserved in mice and men, indicating that this regulatory feature may be an important aspect of TLR3 biology. 
